Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Eliem Therapeutics Inc.

Eliem Therapeutics, Inc. is a clinical stage biotechnology company focused on developing therapies for neuronal excitability disorders with the goal of restoring balance in both the peripheral and central nervous systems to help patients live on their own terms. Eliem channels its experience, energy, and passion for improving patients’ quality of life by developing life-changing novel therapies for disorders such as chronic pain, depression, epilepsy, focal onset seizures, and anxiety – conditions that make simple daily activities challenging for impacted patients. At its core, the Eliem team is motivated by the promise of helping patients live happier, more fulfilling lives. *


Period Start 2019-01-01 established
  Group Eliem Therapeutics (Group)
Products Industry neuropathic drug
  Industry 2 drug development
Person Person Azelby, Robert (Bob) (Eliem Therapeutics 202103 CEO before Alder BioPharmaceuticals + Juno Tx + Amgen)
  Street 23515 NE Novelty Hill Road
Suite B221 #125
  City 98053 Redmond, WA
    Address record changed: 2021-04-05
Basic data Employees n. a.
    * Document for �About Section�: Eliem Therapeutics, Inc.. (3/25/21). "Press Release: Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders". Seattle, WA & Cambrigde.
Record changed: 2021-04-06


Picture [iito] Plain Stupid Simple 650x80px

More documents for Eliem Therapeutics (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top